146 related articles for article (PubMed ID: 30581832)
1. Ventilator-associated pneumonia related to ESBL-producing gram negative bacilli.
Pilmis B; Zahar JR
Ann Transl Med; 2018 Nov; 6(21):424. PubMed ID: 30581832
[TBL] [Abstract][Full Text] [Related]
2. How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?
Timsit JF; Pilmis B; Zahar JR
Semin Respir Crit Care Med; 2017 Jun; 38(3):287-300. PubMed ID: 28578553
[TBL] [Abstract][Full Text] [Related]
3. Frequency, associated factors and outcome of multi-drug-resistant intensive care unit-acquired pneumonia among patients colonized with extended-spectrum β-lactamase-producing Enterobacteriaceae.
Razazi K; Mekontso Dessap A; Carteaux G; Jansen C; Decousser JW; de Prost N; Brun-Buisson C
Ann Intensive Care; 2017 Dec; 7(1):61. PubMed ID: 28608133
[TBL] [Abstract][Full Text] [Related]
4. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF;
J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492
[TBL] [Abstract][Full Text] [Related]
5. Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers.
Andremont O; Armand-Lefevre L; Dupuis C; de Montmollin E; Ruckly S; Lucet JC; Smonig R; Magalhaes E; Ruppé E; Mourvillier B; Lebut J; Lermuzeaux M; Sonneville R; Bouadma L; Timsit JF;
Intensive Care Med; 2020 Jun; 46(6):1232-1242. PubMed ID: 32313993
[TBL] [Abstract][Full Text] [Related]
6. Relationship between digestive tract colonization and subsequent ventilator-associated pneumonia related to ESBL-producing Enterobacteriaceae.
Houard M; Rouzé A; Ledoux G; Six S; Jaillette E; Poissy J; Préau S; Wallet F; Labreuche J; Nseir S; Voisin B
PLoS One; 2018; 13(8):e0201688. PubMed ID: 30089150
[TBL] [Abstract][Full Text] [Related]
7. ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome.
Emmanuel Martinez A; Widmer A; Frei R; Pargger H; Tuchscherer D; Marsch S; Egli A; Tschudin-Sutter S
Infect Control Hosp Epidemiol; 2019 Apr; 40(4):408-413. PubMed ID: 30786948
[TBL] [Abstract][Full Text] [Related]
8. Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review.
Prevel R; Boyer A; M'Zali F; Lasheras A; Zahar JR; Rogues AM; Gruson D
Crit Care; 2019 May; 23(1):170. PubMed ID: 31088542
[TBL] [Abstract][Full Text] [Related]
9. Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae.
Barbier F; Bailly S; Schwebel C; Papazian L; Azoulay É; Kallel H; Siami S; Argaud L; Marcotte G; Misset B; Reignier J; Darmon M; Zahar JR; Goldgran-Toledano D; de Montmollin É; Souweine B; Mourvillier B; Timsit JF;
Intensive Care Med; 2018 May; 44(5):616-626. PubMed ID: 29663045
[TBL] [Abstract][Full Text] [Related]
10. Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.
Pilmis B; Cattoir V; Lecointe D; Limelette A; Grall I; Mizrahi A; Marcade G; Poilane I; Guillard T; Bourgeois Nicolaos N; Zahar JR; Le Monnier A
J Hosp Infect; 2018 Mar; 98(3):247-252. PubMed ID: 29222035
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum beta-lactamase-producing organisms in an intensive care unit.
Bassetti M; Righi E; Fasce R; Molinari MP; Rosso R; Di Biagio A; Mussap M; Pallavicini FB; Viscoli C
J Antimicrob Chemother; 2007 Aug; 60(2):433-5. PubMed ID: 17540673
[TBL] [Abstract][Full Text] [Related]
12. β LACTA test performance for detection of extended-spectrum β-lactamase-producing Gram-negative bacilli directly on bronchial aspirates samples: a validation study.
Gallah S; Benzerara Y; Tankovic J; Woerther PL; Bensekri H; Mainardi JL; Arlet G; Vimont S; Garnier M
Clin Microbiol Infect; 2018 Apr; 24(4):402-408. PubMed ID: 28782646
[TBL] [Abstract][Full Text] [Related]
13. Cessation of screening for intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions.
Jalalzaï W; Boutrot M; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F
Clin Microbiol Infect; 2018 Apr; 24(4):429.e7-429.e12. PubMed ID: 28962997
[TBL] [Abstract][Full Text] [Related]
14. Microbial profile of early and late onset ventilator associated pneumonia in the intensive care unit of a tertiary care hospital in bangalore, India.
Golia S; K T S; C L V
J Clin Diagn Res; 2013 Nov; 7(11):2462-6. PubMed ID: 24392373
[TBL] [Abstract][Full Text] [Related]
15. Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.
Conen A; Frei R; Adler H; Dangel M; Fux CA; Widmer AF
PLoS One; 2015; 10(3):e0120688. PubMed ID: 25803720
[TBL] [Abstract][Full Text] [Related]
16. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?
Pilmis B; Delory T; Groh M; Weiss E; Emirian A; Lecuyer H; Lesprit P; Zahar JR
Int J Infect Dis; 2015 Oct; 39():62-7. PubMed ID: 26327124
[TBL] [Abstract][Full Text] [Related]
17. Extended-spectrum beta-lactamase--producing enterobacteriaceae in the intensive care unit: acquisition does not mean cross-transmission.
Alves M; Lemire A; Decré D; Margetis D; Bigé N; Pichereau C; Ait-Oufella H; Baudel JL; Offenstadt G; Guidet B; Barbut F; Maury E
BMC Infect Dis; 2016 Apr; 16():147. PubMed ID: 27075040
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
Rattanaumpawan P; Werarak P; Jitmuang A; Kiratisin P; Thamlikitkul V
BMC Infect Dis; 2017 Mar; 17(1):183. PubMed ID: 28249572
[TBL] [Abstract][Full Text] [Related]
19. Comparison of rates of fecal colonization with extended-spectrum beta-lactamase-producing enterobacteria among patients in different wards, outpatients and medical students.
Ebrahimi F; Mózes J; Monostori J; Gorácz O; Fésűs A; Majoros L; Szarka K; Kardos G
Microbiol Immunol; 2016 May; 60(5):285-94. PubMed ID: 26959958
[TBL] [Abstract][Full Text] [Related]
20. Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
Zahar JR; Lesprit P; Ruckly S; Eden A; Hikombo H; Bernard L; Harbarth S; Timsit JF; Brun-Buisson C;
Int J Antimicrob Agents; 2017 Jan; 49(1):67-73. PubMed ID: 27890442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
